Fact Source: Financial Supervisory Service DART / 2024-12-12
Disclosure Type: Sales / Supply Contract
💡 Summary in 3 Seconds
Hanwha Systems has signed a supply contract worth KRW 85.3B (3.48% of 2023 revenue) with a government-funded research institute for electrical/mechanical devices, running through May 31, 2028, with key details withheld due to business confidentiality.
📊 1. [Key Disclosure Details & Financial Highlights]
- Contract Name: Electrical/Mechanical Devices (전기/기계장치)
- Contract Amount: KRW 85,300,000,000 (VAT included / KRW 85.3B)
- Relative Size to Revenue: 3.48% (Based on 2023 consolidated annual revenue of KRW 2.45T)
- Counterparty: Government-funded research institute
- Supply Region: Republic of Korea
- Contract Period: December 11, 2024 ~ May 31, 2028 (approx. 3 years and 5 months)
- Key Contract Terms: Down payment/advance payment excluded (detailed payment terms not specified)
- Contract Date: December 11, 2024
- Disclosure Exemption Details: Key details withheld until May 31, 2028, due to business confidentiality.
- Other Notes: Contract amount and duration remain subject to potential changes based on project progress.
📈 2. [Professional Insight: What This Means for Investors]
This filing details a supply contract executed between Hanwha Systems and a domestic government-funded research institute. Financially, the contract value of KRW 85.3B (incl. VAT) represents 3.48% of Hanwha Systems’ 2023 consolidated annual revenue (approx. KRW 2.45T).
The contract spans approximately 3 years and 5 months, running from December 11, 2024 to May 31, 2028. Key contractual terms have been granted a disclosure exemption until May 31, 2028, under business confidentiality grounds. Contract values and timelines remain subject to adjustments as project milestones progress.
📝 Editor’s Comment (by K-STOCK Editor)
The objective fact established in this disclosure is that Hanwha Systems secured an KRW 85.3B contract for electrical/mechanical devices with a government-funded research institute, equivalent to 3.48% of its 2023 annual revenue.
Moving forward, the primary objective checkpoints for investors are tracking milestone execution over the contract timeline through May 31, 2028, observing the eventual disclosure of withheld details upon exemption expiration, and monitoring for any subsequent regulatory amendment filings. As the disclosure notes that values and durations may shift depending on progress, tracking project implementation remains the reference point.
📢 Disclaimer & Source Notice
Source: This content was newly structured and written based on official data submitted to the Financial Supervisory Service’s Data Analysis, Retrieval and Transfer System (DART).
Investment Risk Warning: This content is provided solely for informational and educational purposes. Under no circumstances does it constitute financial advice or a recommendation to buy or sell any specific stock. All investment decisions and financial responsibilities rest entirely with the individual investor.
Contact: For compliance inquiries or copyright requests, please contact ksb220805@gmail.com.